The following table reconciles GAAP and non-GAAP financial measures for Varian's continuing operations:
Varian Medical Systems, Inc. and Subsidiaries
Ad Statistics
Times Displayed: 22281
Times Visited: 445 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Reconciliation of Preliminary GAAP to Non-GAAP Financial Measures
(Unaudited)
(Dollars and shares in millions, except per share amounts)
Q1
2018
Q1
2017
Non-GAAP adjustments
Amortization of intangible assets (1)
$
3.1
$
2.8
Restructuring charges
—
3.6
Legal costs
—
6.2
Impairment charges
—
38.3
Other (2)
1.5
0.3
Total non-GAAP adjustments to operating earnings
4.6
51.2
Tax effects of non-GAAP adjustments
(1.0)
(11.3)
Significant effects of tax legislation (3)
207.1
—
Total net earnings from continuing operations impact from non-GAAP adjustments
$
210.7
$
39.9
Operating earnings reconciliation
GAAP operating earnings from continuing operations
$
121.4
$
17.4
Total operating earnings from continuing operations impact from non-GAAP adjustments
4.6
51.2
Non-GAAP operating earnings from continuing operations
$
126.0
$
68.6
Net (loss) earnings and net (loss) earnings per diluted share reconciliation
GAAP net (loss) earnings from continuing operations attributable to Varian (4)
$
(112.3)
$
7.6
Total net earnings from continuing operations impact from non-GAAP adjustments
210.7
39.9
Non-GAAP net earnings from continuing operations attributable to Varian
$
98.4
$
47.5
GAAP net (loss) earnings per diluted share from continuing operations
$
(1.22)
$
0.08
Non-GAAP net earnings per diluted share from continuing operations
$
1.06
$
0.50
Shares used in computing GAAP net earnings per diluted share
91.6
94.2
Shares used in computing non-GAAP net earnings per diluted share
92.7
94.2
(1)
Includes $1.2 million and $1.3 million, respectively in cost of revenues for the periods presented.
(2)
Other includes acquisition-related expenses and benefits.
(3)
Represents the tax effect of a change in law related to the U.S. Tax Cuts and Jobs Act. The corporate rate reduction results in a remeasurement of our Deferred Tax Assets of $37.8 million. The mandatory deemed repatriation of unremitted foreign earnings results in an estimated charge of $169.3 million.
(4)
Excludes immaterial net earnings (loss) from continuing operations attributable to noncontrolling interests for the periods presented.
SOURCE Varian
Back to HCB News
